Ignite Creation Date:
2024-05-05 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00562640
Status:
COMPLETED
Last Update Posted:
2023-09-15
First Post:
2007-11-21
Brief Title:
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Fludarabine Treatment Closed as of 12012009
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Fallopian Tube Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| 06-155 | View |
| recurrent ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| recurrent primary peritoneal cavity cancer | View |
| stage IIIA primary peritoneal cavity cancer | View |
| stage IIIB primary peritoneal cavity cancer | View |
| stage IIIC primary peritoneal cavity cancer | View |
| stage IV primary peritoneal cavity cancer | View |
| recurrent fallopian tube cancer | View |
| stage IIIA fallopian tube cancer | View |
| stage IIIB fallopian tube cancer | View |
| stage IIIC fallopian tube cancer | View |
| stage IV fallopian tube cancer | View |
| stage IIIA ovarian epithelial cancer | View |
| stage IIIB ovarian epithelial cancer | View |
| stage IIIC ovarian epithelial cancer | View |